Annual SG&A
$200.93 M
+$26.88 M+15.44%
31 December 2023
Summary:
Legend Biotech annual selling, general & administrative expenses is currently $200.93 million, with the most recent change of +$26.88 million (+15.44%) on 31 December 2023. During the last 3 years, it has risen by +$128.22 million (+176.36%). LEGN annual SG&A is now at all-time high.LEGN Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$79.57 M
+$14.15 M+21.64%
30 September 2024
Summary:
Legend Biotech quarterly selling, general & administrative expenses is currently $79.57 million, with the most recent change of +$14.15 million (+21.64%) on 30 September 2024. Over the past year, it has increased by +$30.37 million (+61.72%). LEGN quarterly SG&A is now at all-time high.LEGN Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$6.28 B
-$348.13 M-5.87%
30 September 2024
Summary:
Legend Biotech TTM selling, general & administrative expenses is currently -$6.28 billion, with the most recent change of -$348.13 million (-5.87%) on 30 September 2024. Over the past year, it has dropped by -$6.47 billion (-3387.11%). LEGN TTM SG&A is now -5289.34% below its all-time high of $263.52 million, reached on 30 September 2024.LEGN TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LEGN Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +15.4% | +61.7% | -3387.1% |
| 3 y3 years | +176.4% | +153.9% | -5662.9% |
| 5 y5 years | +5013.9% | +1133.3% | -10000.0% |
LEGN Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +176.4% | at high | +153.9% | -1107.4% | at low |
| 5 y | 5 years | at high | +5013.9% | at high | +1133.3% | -5289.3% | at low |
| alltime | all time | at high | +5013.9% | at high | +1960.9% | -5289.3% | at low |
Legend Biotech Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $79.57 M(+21.6%) | $263.52 M(+13.0%) |
| June 2024 | - | $65.42 M(+16.5%) | $233.15 M(+7.5%) |
| Mar 2024 | - | $56.15 M(-10.0%) | $216.92 M(+8.0%) |
| Dec 2023 | $200.93 M(+15.4%) | $62.38 M(+26.8%) | $200.93 M(+5.2%) |
| Sept 2023 | - | $49.20 M(+0.0%) | $191.05 M(+3.9%) |
| June 2023 | - | $49.18 M(+22.5%) | $183.94 M(+2.0%) |
| Mar 2023 | - | $40.16 M(-23.5%) | $180.25 M(+3.6%) |
| Dec 2022 | $174.05 M(+16.4%) | $52.50 M(+24.7%) | $174.05 M(-9.1%) |
| Sept 2022 | - | $42.09 M(-7.5%) | $191.52 M(+6.0%) |
| June 2022 | - | $45.49 M(+34.0%) | $180.76 M(+12.1%) |
| Mar 2022 | - | $33.96 M(-51.5%) | $161.30 M(+7.9%) |
| Dec 2021 | $149.50 M | $69.97 M(+123.3%) | $149.53 M(+32.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2021 | - | $31.34 M(+20.4%) | $112.89 M(+16.5%) |
| June 2021 | - | $26.03 M(+17.4%) | $96.88 M(+14.1%) |
| Mar 2021 | - | $22.18 M(-33.5%) | $84.91 M(+16.8%) |
| Dec 2020 | $72.70 M(+124.6%) | $33.34 M(+117.6%) | $72.70 M(+32.7%) |
| Sept 2020 | - | $15.32 M(+9.0%) | $54.79 M(+19.3%) |
| June 2020 | - | $14.06 M(+41.0%) | $45.91 M(+19.3%) |
| Mar 2020 | - | $9.97 M(-35.3%) | $38.49 M(+18.9%) |
| Dec 2019 | $32.37 M(+723.9%) | $15.42 M(+139.0%) | $32.37 M(+91.0%) |
| Sept 2019 | - | $6.45 M(-2.8%) | $16.95 M(+61.5%) |
| June 2019 | - | $6.64 M(+71.9%) | $10.50 M(+171.9%) |
| Mar 2019 | - | $3.86 M | $3.86 M |
| Dec 2018 | $3.93 M | - | - |
FAQ
- What is Legend Biotech annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Legend Biotech?
- What is Legend Biotech annual SG&A year-on-year change?
- What is Legend Biotech quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Legend Biotech?
- What is Legend Biotech quarterly SG&A year-on-year change?
- What is Legend Biotech TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Legend Biotech?
- What is Legend Biotech TTM SG&A year-on-year change?
What is Legend Biotech annual selling, general & administrative expenses?
The current annual SG&A of LEGN is $200.93 M
What is the all time high annual SG&A for Legend Biotech?
Legend Biotech all-time high annual selling, general & administrative expenses is $200.93 M
What is Legend Biotech annual SG&A year-on-year change?
Over the past year, LEGN annual selling, general & administrative expenses has changed by +$26.88 M (+15.44%)
What is Legend Biotech quarterly selling, general & administrative expenses?
The current quarterly SG&A of LEGN is $79.57 M
What is the all time high quarterly SG&A for Legend Biotech?
Legend Biotech all-time high quarterly selling, general & administrative expenses is $79.57 M
What is Legend Biotech quarterly SG&A year-on-year change?
Over the past year, LEGN quarterly selling, general & administrative expenses has changed by +$30.37 M (+61.72%)
What is Legend Biotech TTM selling, general & administrative expenses?
The current TTM SG&A of LEGN is -$6.28 B
What is the all time high TTM SG&A for Legend Biotech?
Legend Biotech all-time high TTM selling, general & administrative expenses is $263.52 M
What is Legend Biotech TTM SG&A year-on-year change?
Over the past year, LEGN TTM selling, general & administrative expenses has changed by -$6.47 B (-3387.11%)